Business Wire - December 12, 2005
Dr. Opravil is Titular Professor of Infectious Diseases and Internal Medicine at the University of Zurich, Switzerland, and was a winner of the 1996 Pfizer Research Prize in Infectious Diseases. Dr. Opravil's research has included clinical studies involving pathogenesis and the treatment of HIV infection. He has been a member of the Scientific Board of the Swiss HIV Cohort Study since 1995. As Attending Physician at the University Hospital of Zurich, Dr. Opravil also works as a consultant for infectious diseases and supervises a large, outpatient infectious diseases clinic.
Since it was launched at the International AIDS Conference in Durban, South Africa in July 2000, HIV Clinical Trials has published the work of more than 1,000 leading researchers in HIV therapeutics. "HIV Clinical Trials has a unique pan-continental perspective," said Kenneth Killion, HCT Publisher. "As an unbiased and independent journal, HCT provides valuable, global access to late-breaking HIV data and includes reports of original HIV clinical trials. We are honored that Dr. Opravil will serve as our new Editor-in-Chief and we thank Dr. Staquet for his outstanding leadership in this role over the past six years."
About HIV Clinical Trials
HIV Clinical Trials, published by Thomas Land Publishers, is available in print and online. Major educational and research institutions, public health governmental bodies, and pharmaceutical firms make extensive use of HCT's online archive of all published articles. Thomas Land Publishers' journals also include Topics in Stroke Rehabilitation and Topics in Spinal Cord Injury Rehabilitation.
About Thomas Land Publishers, Inc.
Founded in 1998, Thomas Land Publishers is a privately owned company that specializes in rehabilitation and clinical medicine journals, books, and electronic media. Thomas Land publications are peer-reviewed and independent. As a leading knowledge partner for the health professions, Thomas Land Publishers is able to react quickly to changes in the field and respond to customers' needs.
Contacts
Thomas Land Publishers
Ken Killion, 314-963-7445, ken@thomasland.com
www.thomasland.com
051212
BW051209
Copyright © 2005 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .